Does DAROLUTAMIDE Cause Prostate cancer metastatic? 17 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Prostate cancer metastatic have been filed in association with DAROLUTAMIDE (NUBEQA). This represents 0.5% of all adverse event reports for DAROLUTAMIDE.
17
Reports of Prostate cancer metastatic with DAROLUTAMIDE
0.5%
of all DAROLUTAMIDE reports
5
Deaths
2
Hospitalizations
How Dangerous Is Prostate cancer metastatic From DAROLUTAMIDE?
Of the 17 reports, 5 (29.4%) resulted in death, 2 (11.8%) required hospitalization.
Is Prostate cancer metastatic Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAROLUTAMIDE. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does DAROLUTAMIDE Cause?
Fatigue (384)
Death (361)
Hot flush (203)
Asthenia (173)
Prostatic specific antigen increased (156)
Off label use (133)
Neuropathy peripheral (127)
Diarrhoea (122)
Dizziness (122)
Rash (116)
What Other Drugs Cause Prostate cancer metastatic?
LEUPROLIDE (747)
ABIRATERONE (488)
DOCETAXEL (198)
ENZALUTAMIDE (165)
DENOSUMAB (144)
PREDNISONE (139)
RADIUM RA-223 DICHLORIDE (120)
CABAZITAXEL (74)
BICALUTAMIDE (72)
ZOLEDRONIC ACID (71)
Which DAROLUTAMIDE Alternatives Have Lower Prostate cancer metastatic Risk?
DAROLUTAMIDE vs DARUNAVIR
DAROLUTAMIDE vs DARUNAVIR ETHANOLATE
DAROLUTAMIDE vs DARUNAVIR\RITONAVIR
DAROLUTAMIDE vs DASABUVIR
DAROLUTAMIDE vs DASABUVIR\OMBITASVIR HEMINONAHYDRATE\PARITAPREVIR\RITONAVIR